41
Participants
Start Date
July 15, 2019
Primary Completion Date
November 26, 2024
Study Completion Date
November 26, 2024
Nivolumab
"Solution for intravenous injection 10 mg/ml. Initial dose : 3 mg/kg Nivolumab will be given at 3 mg/kg/injection every two weeks from the first day of radiotherapy to the last day of chemotherapy.~One de-escalation dose : 1 mg/kg"
Temozolomide
Capsules: 5, 20, 100, 140, 180 and 250 mg orally. Temozolomide will be given at 75mg/m2/day from the day of start of radiotherapy to the last day of radiotherapy, then, after one month rest at 200mg/m2/day for five consecutive days for 12 cycles (28 days cycle).
Radiotherapy
Total dose of 54 Gray(Gy) units delivered in 30 daily fractions of 1.8 Gy over 6 weeks during the chemoradiation period.
Hôpital des enfants, Toulouse
CHU Angers, Angers
Centre Oscar Lambret, Lille
CHU Hautepierre, Strasbourg
Centre Léon Bérard, Lyon
Institut Curie, Paris
Gustave Roussy, Villejuif
Gustave Roussy, Cancer Campus, Grand Paris
OTHER